Amorolfine API

Amorolfine API
About Haorui Products Technology Contact
 

Amorolfine API

 

Amorolfine API

 

Amorolfine API

 

 

 

 

 

 

Amorolfine API

 

Haorui supplies high quality Amorolfine API produced by our GMP facility that has been successfully inspected by the FDA. We offer competitive prices and support our products with reliable technical and regulatory services. Amorolfine API is available from R&D to commercial quantities. Please contact us for more details.

 

  The following information is provided for general information purposes ONLY.

 

What is Amorolfine HCI?

Amorolfine is a morpholine derivative that is used topically as an antifungal agent. Amorolfine has a broad spectrum of activity, including dermatophytes filamentous and dematiaceous fungi, yeasts and dimorphic fungi. Its activity is fungicidal for most species. Amorolfine can penetrate into the nail rapidly and achieve concentrations higher than the MICs obtained for most of the fungi causing onychomycosis. Amorolfine’s clearance is slow following topical application. Amorolfine has been ineffective when administered orally to animals with systemic fungal infections. This lack of activity may be due to protein binding and/or rapid metabolism of the drug.

How does Amorolfine HCI work?

Amorolfine blocks delta 14 reduction and delta 7-8 isomerisation, which causes depletion of ergosterol and accumulation of ignosterol in fungal cytoplasmic membrane. Fungal cell wall becomes thicker and chitin deposits are formed inside and outside the cell wall.

 

What is Amorolfine HCI used for?

Amorolfine is used to treat tinea (fungal) infections of the finger and toe nails. Tinea infections are also sometimes known as ringworm, which may be caught from another person, from an animal, from soil, from the floors of showers, or from household objects, such as chairs or carpet. While amorolfine achieves clinical treatment in around 40 to 55% of patients with mild tinea infections, those with severe tinea infections involving the nail bed require systemic treatment.

 

Amorolfine is also effective also to various superficial dermatomycosis. However, cream and vaginal tablet formulations of amorolfine are not available anymore.  

 

How many doses of Amorolfine are usually taken?

Amorolfine 5% nail lacquer is applied once or twice a week for up to 6 months in tinea infections

 

In various superficial dermatomycoses, amorolfine cream has previously been used once daily on the infected area for up to 6 weeks

 

Precautions of using Amorolfine:

Before using any of this preparation make sure your doctor or pharmacist knows:

bullet

if you are pregnant, trying for a baby or breast-feeding

bullet

if you have ever had an allergic reaction to this or any other medicine

bullet

if you are using any other preparations, including those available to buy without a prescription, herbal and complementary medicines

 

Amorolfine HCI side effects

Amorolfine occasionally causes skin irritation such as redness, itching, or a burning sensation. This should soon disappear. If it doesn't or if it becomes severe, stop using Amorolfine and ask your doctor or pharmacist for advice.

 

Storage of Amorolfine

bullet

Keep out of reach of children.

bullet

Store in a cool, dry place, away from direct light and heat.

bullet

Never keep out of date or unwanted medicines. Discard them safely out of the reach of children or take them to your local pharmacist who will dispose of unwanted medicines for you.

Usage of Amorolfine

bullet

Use Amorolfine exactly as directed by your doctor.

bullet

Always read the manufacturer's information leaflet, if possible, before beginning treatment. This will contain instructions for using the product.

bullet

Amorolfine  is usually applied once or twice a week, after filing and cleaning the nails, as directed.

bullet

Allow Amorolfine to dry after applying. This usually takes around three minutes.

 

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.    

 

                                         Home | Sitemap
Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved